Gold has big year in 2020 and outlook for this year robust. Learn about monetary expansion and gold future prices.Read More
The gold futures price reached US$1,767/ounce this week before retreating, which was the second time it has surpassed US$1,760 in the past two months, marking some of gold's highest levels in several years.Read More
New Found Gold (TSXV: NFG; NYSE-AM: NFGC) says it has discovered a new zone and vein extending mineralization south of the Keats deposit at its Queensway project in central Newfoundland. Drilling along the Appleton fault at the project, 15 km west of Gander, N.L., discovered the new Trans Canada Highway zone and the Rocket vein at the Knob target. The drill program also returned more intercep...Read More
GoviEx Uranium (TSXV: GXU; US-OTC: GVXXF) is selling its uranium-silver-copper Falea project in Mali to African Energy Metals (TSXV: CUCO; US-OTC: NDENF) in a $5.5 million cash and share deal.The project is about 350 km west of Mali's capital Bamako and roughly 240 km south of the city of Kayes. It is also about 80 km to the east of Areva's Saraya East uranium deposit in Senegal and approximately...Read More
In the wake of the Bre-X Minerals gold salting fraud of the late 1990s, Canada's regulators introduced National Instrument 43-101 in 2001. The regulation, which spelled out standards of disclosure for mineral projects and put the onus on the "qualified person" - a professional responsible for the information in a technical report - earned back the trust of investors, prevented similar frauds, and...Read More
Antofagasta (LSE: ANTO) produced 646,200 tonnes of copper at net cash costs of US$1.61 per lb. last year and forecasts this year it will produce 670,000 to 710,000 tonnes at net cash costs of US$1.65 per pound, the company said in its Q4 production report Wednesday.The copper miner said 2022 production was 10.4% lower than 2021 due to a reduction in throughput at its flagship Los Pelambres mine, 2...Read More
Alcoa Corporation (NYSE:NYSE:AA) Q4 2022 Earnings Conference Call January 18, 2023 5:00 PM ETCompany ParticipantsJames Dwyer - Vice President, Investor RelationsRoy Harvey - President and...Read full newsRead More
The following slide deck was published by Alcoa Corporation in conjunction with their 2022 Q4 earnings call.Read full newsRead More
Teva Pharmaceutical's undoing was its $40.5B deal to acquire Allergan's generic drug business in 2015. Read why TEVA's 56% run in the stock price makes it a Sell.Read full newsRead More
Kinder Morgan, Inc. (NYSE:NYSE:KMI) Q4 2022 Results Conference Call January 18, 2023 4:30 PM ETCompany ParticipantsRich Kinder - Executive ChairmanSteve Kean - CEOKim Dang - PresidentTom...Read full newsRead More
Alpha Metallurgical Resources represents a very favorable risk-reward at ~1.1X EV/EBITDA. Click here to read why AMR stock is a Buy.Read full newsRead More
CenterPoint Energy is positioned to deliver reasonably strong growth through the end of the decade. See why CNP looks a bit expensive relative to its peers.Read full newsRead More
Bristol Myers Squibb touted the launch of 9 new products in the U.S. While these products need more insurance coverage, read why I still rate BMY stock a Buy.Read full newsRead More
Relay Therapeutics discovers drugs using a novel computational approach. Though I like RLAY stock, see why I will wait for a correction before taking a call.Read full newsRead More
I see very bright earnings prospects for Enterprise Products Partners L.P. both in the near term and also long term. Click here to see my take on EPD stock.Read full newsRead More
Bentley Systems stands out by offering comprehensive solutions that cover the entire lifecycle of an infrastructure project. Read more to see why BSY is a Buy.Read full newsRead More
CNX Resources Corp. is an independent E&P focused on the production of natural gas in the Appalachian region. Read why we think CNX stock looks incredibly cheap.Read full newsRead More
Sportradar is set to capitalize on sports betting legalization and tailwinds in 2023. Read more to see my 5 reasons to invest in SRAD stock in 2023.Read full newsRead More
New year, new investment opportunities. This month's dividend growth screener article presents ideas worth exploring further. Read more to see our picks.Read full newsRead More
BridgeBio Pharma has a lot of irons in the fire. Despite getting approvals for two products, there's hardly any revenue. Read more to see our stance on BBIO.Read full newsRead More
Since 2020, Alibaba insiders Masa Son, Jack Ma, and Joe Tsai have done nothing but sell shares. Read why I still maintain a Buy rating on BABA stock.Read full newsRead More
The war in Ukraine is the biggest land conflict in Europe since WWII. See my analysis of the implications on the economy and markets.Read full newsRead More